IFNA17 and autoimmune polyendocrine syndrome type 1: In contrast to the results by Meyer et al., we found strong neutralization of IFNα- and IFNω-dependent cellular response in all tested APS1 sera, with no difference between patients with type 1 diabetes compared to those without diabetes (Figure 2).